"Another study shows that a "liquid biopsy" that measures levels of circulating tumor DNA (ctDNA) can be useful for monitoring cancer patients â€“ this time patients with ovarian cancer.
At a recent cancer research meeting, experts predi"...
Caution should be exercised to prevent inadvertent overdosage with PLATINOL.
Acute overdosage with this drug may result in kidney failure, liver failure, deafness, ocular toxicity (including detachment of the retina), significant myelosuppression, intractable nausea and vomiting and/or neuritis. In addition, death can occur following overdosage.
No proven antidotes have been established for PLATINOL overdosage. Hemodialysis, even when initiated four hours after the overdosage, appears to have little effect on removing platinum from the body because of PLATINOL's rapid and high degree of protein binding. Management of overdosage should include general supportive measures to sustain the patient through any period of toxicity that may occur.
PLATINOL is contraindicated in patients with preexisting renal impairment. PLATINOL should not be employed in myelosuppressed patients, or in patients with hearing impairment.
PLATINOL is contraindicated in patients with a history of allergic reactions to PLATINOL or other platinum-containing compounds.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 11/16/2016
Additional Platinol Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.